Industry Research Reports

Home > Reports > Pharma & Healthcare > Recombinant Human Erythropoietin (rhEPO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Recombinant Human Erythropoietin (rhEPO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 94 Pages

Report ld: 2340197

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

The global market for Recombinant Human Erythropoietin (rhEPO) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Recombinant Human Erythropoietin (rhEPO) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Recombinant Human Erythropoietin (rhEPO) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Recombinant Human Erythropoietin (rhEPO) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Recombinant Human Erythropoietin (rhEPO) include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Erythropoietin (rhEPO), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Human Erythropoietin (rhEPO) by region & country, by Type, and by Application.

The Recombinant Human Erythropoietin (rhEPO) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Erythropoietin (rhEPO).

Market Segmentation

Report Metric
Details
Report Title
Recombinant Human Erythropoietin (rhEPO) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Recombinant Human Erythropoietin (rhEPO) Companies Covered
3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus, Dragon Pharma
Global Recombinant Human Erythropoietin (rhEPO) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Recombinant Human Erythropoietin (rhEPO) Market, Segment by Type
ESRD

Cancer

HIV

Wounds and Neural Disease
Global Recombinant Human Erythropoietin (rhEPO) Market, Segment by Application
Hospitals

Retail Pharmacies
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Recombinant Human Erythropoietin (rhEPO) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Recombinant Human Erythropoietin (rhEPO) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Recombinant Human Erythropoietin (rhEPO) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Recombinant Human Erythropoietin (rhEPO) Product Introduction
    1.2 Global Recombinant Human Erythropoietin (rhEPO) Market Size Forecast
        1.2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Value (2019-2030)
        1.2.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume (2019-2030)
        1.2.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Price (2019-2030)
    1.3 Recombinant Human Erythropoietin (rhEPO) Market Trends & Drivers
        1.3.1 Recombinant Human Erythropoietin (rhEPO) Industry Trends
        1.3.2 Recombinant Human Erythropoietin (rhEPO) Market Drivers & Opportunity
        1.3.3 Recombinant Human Erythropoietin (rhEPO) Market Challenges
        1.3.4 Recombinant Human Erythropoietin (rhEPO) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Recombinant Human Erythropoietin (rhEPO) Players Revenue Ranking (2023)
    2.2 Global Recombinant Human Erythropoietin (rhEPO) Revenue by Company (2019-2024)
    2.3 Global Recombinant Human Erythropoietin (rhEPO) Players Sales Volume Ranking (2023)
    2.4 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Company Players (2019-2024)
    2.5 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Company (2019-2024)
    2.6 Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Recombinant Human Erythropoietin (rhEPO)
    2.9 Recombinant Human Erythropoietin (rhEPO) Market Competitive Analysis
        2.9.1 Recombinant Human Erythropoietin (rhEPO) Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Recombinant Human Erythropoietin (rhEPO) Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Erythropoietin (rhEPO) as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 ESRD
        3.1.2 Cancer
        3.1.3 HIV
        3.1.4 Wounds and Neural Disease
    3.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Type
        3.2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Value, by Type (2019-2030)
        3.2.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Value, by Type (%) (2019-2030)
    3.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Type
        3.3.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume, by Type (2019-2030)
        3.3.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume, by Type (%) (2019-2030)
    3.4 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Retail Pharmacies
    4.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Application
        4.2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Value, by Application (2019-2030)
        4.2.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Value, by Application (%) (2019-2030)
    4.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Application
        4.3.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume, by Application (2019-2030)
        4.3.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume, by Application (%) (2019-2030)
    4.4 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region
        5.1.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region (2019-2024)
        5.1.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region (2025-2030)
        5.1.4 Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region (%), (2019-2030)
    5.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region
        5.2.1 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region (2019-2024)
        5.2.3 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region (2025-2030)
        5.2.4 Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region (%), (2019-2030)
    5.3 Global Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        5.4.2 North America Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        5.5.2 Europe Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        5.6.2 Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        5.7.2 South America Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        5.8.2 Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Value
        6.2.1 Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        6.3.2 United States Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Recombinant Human Erythropoietin (rhEPO) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        6.4.2 Europe Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Recombinant Human Erythropoietin (rhEPO) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        6.5.2 China Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Recombinant Human Erythropoietin (rhEPO) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        6.6.2 Japan Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Recombinant Human Erythropoietin (rhEPO) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        6.7.2 South Korea Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Recombinant Human Erythropoietin (rhEPO) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        6.8.2 Southeast Asia Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Recombinant Human Erythropoietin (rhEPO) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019-2030
        6.9.2 India Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Recombinant Human Erythropoietin (rhEPO) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 3SBio
        7.1.1 3SBio Company Information
        7.1.2 3SBio Introduction and Business Overview
        7.1.3 3SBio Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 3SBio Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.1.5 3SBio Recent Development
    7.2 Shanghai Chemo
        7.2.1 Shanghai Chemo Company Information
        7.2.2 Shanghai Chemo Introduction and Business Overview
        7.2.3 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.2.5 Shanghai Chemo Recent Development
    7.3 Chengdu Diao
        7.3.1 Chengdu Diao Company Information
        7.3.2 Chengdu Diao Introduction and Business Overview
        7.3.3 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.3.5 Chengdu Diao Recent Development
    7.4 NCPC Genetech
        7.4.1 NCPC Genetech Company Information
        7.4.2 NCPC Genetech Introduction and Business Overview
        7.4.3 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.4.5 NCPC Genetech Recent Development
    7.5 Kyowa Hakko Kirin
        7.5.1 Kyowa Hakko Kirin Company Information
        7.5.2 Kyowa Hakko Kirin Introduction and Business Overview
        7.5.3 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.5.5 Kyowa Hakko Kirin Recent Development
    7.6 Shandong Kexing
        7.6.1 Shandong Kexing Company Information
        7.6.2 Shandong Kexing Introduction and Business Overview
        7.6.3 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.6.5 Shandong Kexing Recent Development
    7.7 Ahua Pharmaceutical
        7.7.1 Ahua Pharmaceutical Company Information
        7.7.2 Ahua Pharmaceutical Introduction and Business Overview
        7.7.3 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.7.5 Ahua Pharmaceutical Recent Development
    7.8 Biosidus
        7.8.1 Biosidus Company Information
        7.8.2 Biosidus Introduction and Business Overview
        7.8.3 Biosidus Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Biosidus Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.8.5 Biosidus Recent Development
    7.9 Dragon Pharma
        7.9.1 Dragon Pharma Company Information
        7.9.2 Dragon Pharma Introduction and Business Overview
        7.9.3 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product Offerings
        7.9.5 Dragon Pharma Recent Development

 8 Industry Chain Analysis
    8.1 Recombinant Human Erythropoietin (rhEPO) Industrial Chain
    8.2 Recombinant Human Erythropoietin (rhEPO) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Recombinant Human Erythropoietin (rhEPO) Sales Model
        8.5.2 Sales Channel
        8.5.3 Recombinant Human Erythropoietin (rhEPO) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Recombinant Human Erythropoietin (rhEPO) Market Trends
    Table 2. Recombinant Human Erythropoietin (rhEPO) Market Drivers & Opportunity
    Table 3. Recombinant Human Erythropoietin (rhEPO) Market Challenges
    Table 4. Recombinant Human Erythropoietin (rhEPO) Market Restraints
    Table 5. Global Recombinant Human Erythropoietin (rhEPO) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Recombinant Human Erythropoietin (rhEPO) Revenue Market Share by Company (2019-2024)
    Table 7. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Recombinant Human Erythropoietin (rhEPO) Price by Company (2019-2024) & (USD/Unit)
    Table 10. Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Recombinant Human Erythropoietin (rhEPO) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Human Erythropoietin (rhEPO)
    Table 13. Global Recombinant Human Erythropoietin (rhEPO) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Erythropoietin (rhEPO) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Recombinant Human Erythropoietin (rhEPO) Price by Type (2019-2024) & (USD/Unit)
    Table 27. Global Recombinant Human Erythropoietin (rhEPO) Price by Type (2025-2030) & (USD/Unit)
    Table 28. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Recombinant Human Erythropoietin (rhEPO) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Recombinant Human Erythropoietin (rhEPO) Price by Application (2019-2024) & (USD/Unit)
    Table 39. Global Recombinant Human Erythropoietin (rhEPO) Price by Application (2025-2030) & (USD/Unit)
    Table 40. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2019-2024) & (USD/Unit)
    Table 51. Global Recombinant Human Erythropoietin (rhEPO) Average Price by Region (2025-2030) & (USD/Unit)
    Table 52. Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Volume, (2025-2030) & (K Units)
    Table 57. 3SBio Company Information
    Table 58. 3SBio Introduction and Business Overview
    Table 59. 3SBio Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 60. 3SBio Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 61. 3SBio Recent Development
    Table 62. Shanghai Chemo Company Information
    Table 63. Shanghai Chemo Introduction and Business Overview
    Table 64. Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 65. Shanghai Chemo Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 66. Shanghai Chemo Recent Development
    Table 67. Chengdu Diao Company Information
    Table 68. Chengdu Diao Introduction and Business Overview
    Table 69. Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 70. Chengdu Diao Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 71. Chengdu Diao Recent Development
    Table 72. NCPC Genetech Company Information
    Table 73. NCPC Genetech Introduction and Business Overview
    Table 74. NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 75. NCPC Genetech Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 76. NCPC Genetech Recent Development
    Table 77. Kyowa Hakko Kirin Company Information
    Table 78. Kyowa Hakko Kirin Introduction and Business Overview
    Table 79. Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 80. Kyowa Hakko Kirin Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 81. Kyowa Hakko Kirin Recent Development
    Table 82. Shandong Kexing Company Information
    Table 83. Shandong Kexing Introduction and Business Overview
    Table 84. Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 85. Shandong Kexing Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 86. Shandong Kexing Recent Development
    Table 87. Ahua Pharmaceutical Company Information
    Table 88. Ahua Pharmaceutical Introduction and Business Overview
    Table 89. Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 90. Ahua Pharmaceutical Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 91. Ahua Pharmaceutical Recent Development
    Table 92. Biosidus Company Information
    Table 93. Biosidus Introduction and Business Overview
    Table 94. Biosidus Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 95. Biosidus Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 96. Biosidus Recent Development
    Table 97. Dragon Pharma Company Information
    Table 98. Dragon Pharma Introduction and Business Overview
    Table 99. Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 100. Dragon Pharma Recombinant Human Erythropoietin (rhEPO) Product Offerings
    Table 101. Dragon Pharma Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Recombinant Human Erythropoietin (rhEPO) Downstream Customers
    Table 105. Recombinant Human Erythropoietin (rhEPO) Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Recombinant Human Erythropoietin (rhEPO) Product Picture
    Figure 2. Global Recombinant Human Erythropoietin (rhEPO) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Recombinant Human Erythropoietin (rhEPO) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Recombinant Human Erythropoietin (rhEPO) Sales Price (2019-2030) & (USD/Unit)
    Figure 6. Recombinant Human Erythropoietin (rhEPO) Report Years Considered
    Figure 7. Global Recombinant Human Erythropoietin (rhEPO) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Recombinant Human Erythropoietin (rhEPO) Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Human Erythropoietin (rhEPO) Revenue in 2023
    Figure 10. Recombinant Human Erythropoietin (rhEPO) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. ESRD Picture
    Figure 12. Cancer Picture
    Figure 13. HIV Picture
    Figure 14. Wounds and Neural Disease Picture
    Figure 15. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Recombinant Human Erythropoietin (rhEPO) Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Recombinant Human Erythropoietin (rhEPO) Price by Type (2019-2030) & (USD/Unit)
    Figure 20. Product Picture of Hospitals
    Figure 21. Product Picture of Retail Pharmacies
    Figure 22. Global Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Recombinant Human Erythropoietin (rhEPO) Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Recombinant Human Erythropoietin (rhEPO) Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Recombinant Human Erythropoietin (rhEPO) Price by Application (2019-2030) & (USD/Unit)
    Figure 27. North America Recombinant Human Erythropoietin (rhEPO) Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Recombinant Human Erythropoietin (rhEPO) Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Recombinant Human Erythropoietin (rhEPO) Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Recombinant Human Erythropoietin (rhEPO) Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Recombinant Human Erythropoietin (rhEPO) Sales Volume (%), (2019-2030)
    Figure 39. United States Recombinant Human Erythropoietin (rhEPO) Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Recombinant Human Erythropoietin (rhEPO) Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Recombinant Human Erythropoietin (rhEPO) Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Recombinant Human Erythropoietin (rhEPO) Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Recombinant Human Erythropoietin (rhEPO) Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Recombinant Human Erythropoietin (rhEPO) Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Recombinant Human Erythropoietin (rhEPO) Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Recombinant Human Erythropoietin (rhEPO) Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Recombinant Human Erythropoietin (rhEPO) Sales Value by Application (%), 2023 VS 2030
    Figure 60. Recombinant Human Erythropoietin (rhEPO) Industrial Chain
    Figure 61. Recombinant Human Erythropoietin (rhEPO) Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

The process of supplying EPO externally, usually with the help of recombinant DNA technology in a cell culture, is known as rhEPO. rhEPO is used to treat anemia due to neural diseases, injuries, kidney diseases or cancer.

The global market for Recombinant Human Erythropoietin (rhEPO) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Recombinant Human Erythropoietin (rhEPO) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Recombinant Human Erythropoietin (rhEPO) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Recombinant Human Erythropoietin (rhEPO) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Recombinant Human Erythropoietin (rhEPO) include 3SBio, Shanghai Chemo, Chengdu Diao, NCPC Genetech, Kyowa Hakko Kirin, Shandong Kexing, Ahua Pharmaceutical, Biosidus and Dragon Pharma, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Erythropoietin (rhEPO), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Recombinant Human Erythropoietin (rhEPO) by region & country, by Type, and by Application.

The Recombinant Human Erythropoietin (rhEPO) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Erythropoietin (rhEPO).

Market Segmentation